Semenova, Vera

Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23–May 12, 2020

Havers, F. P., Reed, C., Lim, T., Montgomery, J. M., Klena, J. D., Hall, A. J., Fry, A. M., Cannon, D. L., Chiang, C.-F., Gibbons, A., et al. (2020) · JAMA Internal Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 647

Serologic testing of US blood donations to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-reactive antibodies: December 2019–January 2020

Basavaraju, S. V., Patton, M. E., Grimm, K., Rasheed, M. A. U., Lester, S., Mills, L., Stumpf, M., Freeman, B., Tamin, A., Harcourt, J., et al. (2021) · Clinical Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing

Cited by 110

Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak-Oregon, 2015–2016

McNamara, L. A., Thomas, J. D., MacNeil, J., Chang, H. Y., Day, M., Fisher, E., Martin, S., Poissant, T., Schmink, S. E., Steward-Clark, E., et al. (2017) · The Journal of Infectious Diseases

Bacterial Infections and VaccinesMicrobial infections and disease research

Cited by 72